Authors: | Msaouel, P.; Siefker-Radtke, A.; Sweis, R.; Mortazavi, A.; Vogelzang, N.; Vaishampayan, U.; Bradley, T.; Bupathi, M.; Nordquist, L.; Shaffer, D.; Picus, J.; Yorio, J.; Mao, S.; Doshi, G.; Spitz, D.; Gandhi, S.; Chong, D.; Kalebasty, A. R.; Christensen, J.; Olson, P.; Faltaos, D.; Shazer, R.; Winter, M.; Alvarez, D.; Del-Torossian, H.; Rosenberg, J. |
Abstract Title: | Sitravatinib in combination with nivolumab demonstrates clinical activity in platinum-experienced patients with urothelial carcinoma (UC) who progressed on prior immune checkpoint inhibitor (CPI) |
Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
Journal Title: | Journal for ImmunoTherapy of Cancer |
Volume: | 7 |
Issue: | Suppl. 1 |
Meeting Dates: | 2019 Nov 6-10 |
Meeting Location: | National Harbor, MD |
ISSN: | 2051-1426 |
Publisher: | Biomed Central Ltd |
Date Published: | 2019-11-01 |
Start Page: | 283 |
Language: | English |
ACCESSION: | WOS:000496473200368 |
PROVIDER: | wos |
PMCID: | PMC6833180 |
PUBMED: | 31694708 |
DOI: | 10.1186/s40425-019-0764-0 |
Notes: | Meeting Abstract: O23 -- Source: Wos |